Key Points
- John Charles Rademacher, CEO of Option Care Health, bought 12,500 shares on May 4 at an average price of $21.18 for about $264,750, increasing his holdings to 695,152 shares (a 1.83% ownership rise, ~ $14.72M value).
- The purchase comes while OPCH trades near $21—well below its 50‑ and 200‑day moving averages (~$29.15 and $30.74)—after the company reported quarterly EPS of $0.40 (beating estimates) and set FY2026 guidance of 1.820–1.920 EPS; analysts' consensus is a "Moderate Buy" with an average target of $32.08.
Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) CEO John Charles Rademacher acquired 12,500 shares of Option Care Health stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $21.18 per share, with a total value of $264,750.00. Following the acquisition, the chief executive officer owned 695,152 shares of the company's stock, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Option Care Health Price Performance
Shares of NASDAQ OPCH opened at $21.14 on Tuesday. The firm has a market cap of $3.32 billion, a P/E ratio of 16.39, a price-to-earnings-growth ratio of 1.12 and a beta of 0.68. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The business's 50 day moving average is $29.15 and its 200-day moving average is $30.74.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the previous year, the company posted $0.40 EPS. The firm's quarterly revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts predict that Option Care Health, Inc. will post 1.69 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the company. V Square Quantitative Management LLC bought a new stake in Option Care Health during the fourth quarter worth $25,000. Cornerstone Planning Group LLC boosted its holdings in shares of Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock valued at $30,000 after purchasing an additional 1,067 shares in the last quarter. McIlrath & Eck LLC bought a new position in shares of Option Care Health in the 2nd quarter valued at $37,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health during the 3rd quarter worth $35,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in shares of Option Care Health during the 3rd quarter worth $38,000. 98.05% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
OPCH has been the topic of several research reports. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Tuesday, January 13th. Truist Financial set a $30.00 price objective on shares of Option Care Health in a research note on Friday. Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and set a $22.00 price objective for the company. in a report on Friday. Morgan Stanley raised their target price on shares of Option Care Health from $35.00 to $38.00 and gave the stock an "overweight" rating in a report on Tuesday, January 13th. Finally, TD Cowen dropped their price target on shares of Option Care Health from $37.00 to $23.00 and set a "hold" rating for the company in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $32.08.
Read Our Latest Analysis on OPCH
About Option Care Health
(
Get Free Report)
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
